The G22A polymorphism of the ADA gene and susceptibility to autism spectrum disorders

Journal of Autism and Developmental Disorders

Volumn 38, Issue 1, 2008, Pages 14-19

  Hettinger, Joe A ^a,c   Liu, Xudong ^a,c,d   Holden, Jeanette Jeltje Anne ^a,b,c,d  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c Ongwanada Resource Centre   (Canada)

^d Canadian American Research Consortium   (Canada)

Author keywords

Adenosine deaminase; Autism spectrum disorders; Candidate gene; Hyperuricosuria; Purine metabolism

Indexed keywords

ADENOSINE DEAMINASE;

ALLELE; ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; FAMILY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; NORTH AMERICA; PRIORITY JOURNAL; PURINE METABOLISM;

ADENOSINE DEAMINASE; AUTISTIC DISORDER; CHILD; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; PURINES;

EID: 37849026046     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-006-0354-0     Document Type: Article

References (30)

1. Battistuzzi, G., Iudicone, P., Santolamazza, P., & Petrucci, R. (1981). Activity of adenosine deaminase allelic forms in intact erythrocytes and in lymphocytes. Annals of Human Genetics, 45, 15-19.
2. Bottini, N., De Luca, D., Saccucci, P., Fiumara, A., Elia, M., Porfirio, M. C., et al. (2001). Autism: evidence of association with adenosine deaminase genetic polymorphism. Neurogenetics, 3, 111-113.
3. Chakrabarti, S., & Fombonne, E. (2005). Pervasive developmental disorders in preschool children: confirmation of high prevalence. American Journal of Psychiatry, 162, 1133-1141.
4. Coleman, M., Landgrebe, M. A., & Landgrebe, A. R. (1976). Purine autism. Hyperuricosuria in autistic children: does this identify a subgroup of autism? In M. Coleman (Eds.), The autistic syndromes (pp. 183-214). New York: Elsevier.
5. Evans, H. K., Wylie, A. A., Murphy, S. K., & Jirtle, R. L. (2001). The neuronatin gene resides in a 'micro-imprinted' domain on human chromosome 20q11.2. Genomics, 77, 99-104.
6. Geschwind, D. H., Sowinski, J., Lord, C., Iversen, P., Shestack, J., Jones, P., et al. (2001). The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions. American Journal of Human Genetics, 69, 463-466.
7. Hayward, B. E., Kamiya, M., Strain, L., Moran, V., Campbell, R., Hayashizaki, Y., et al. (1998). The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proceedings of the National Academy of Sciences of the United States of America, 95, 10038-10043.
8. Hirschhorn, R., Yang, D. R., & Israni, A. (1994). An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different chromosomal backgrounds and apparent intragenic crossover. Annals of Human Genetics, 58, 1-9.
9. Korvatska, E., Van de Water, J., Anders, T. F., & Gershwin, M. E. (2002). Genetic and immunologic considerations in autism. Neurobiology of Disease, 9, 107-125.
10. Laird, N., Horvath, S., & Xu, X. (2000). Implementing a unified approach to family based tests of association. Genetic Epidemiology, 19(Suppl1), S36-S42.
11. Lander, E. S. (1996). The new genomics: global views of biology. Science, 274, 536-539.
12. Lord, C., Rutter, M., Goode, S., Heemsbergen, J., Jordan, H., Mawhood, L., et al. (1989). Autism Diagnostic Observation Schedule: a standardized observation of communicative and social behavior. Journal of Autism and Developmental Disorders, 19, 185-212.
13. Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659-685.
14. Nowell, M. A., Hackney, D. B., Muraki, A. S., & Coleman, M. (1990). Varied MR appearance of autism: fifty-three pediatric patients having the full autistic syndrome. Magnetic Resonance Imaging, 8, 811-816.
15. Nyhan, W. L., James, J. A., Teberg, A. J., Sweetman, L., & Nelson, L.G. (1969). A new disorder of purine metabolism with behavioral manifestations. The Journal of Pediatrics, 74, 20-27.
16. Page, T., & Coleman, M. (2000). Purine metabolism abnormalities in a hyperuricosuric subclass of autism. Biochimica et Biophysica Acta, 1500, 291-296.
17. Page, T., & Moseley, C. (2002). Metabolic treatment of hyperuricosuric autism. Progress in Neuro-psychopharmacology and Biological Psychiatry, 26, 397-400.
18. Persico, A. M., Militerni, R., Bravaccio, C., Schneider, C., Melmed, R., Trillo, S., et al. (2000). Adenosine deaminase alleles and autistic disorder: Case-control and family-based association studies. American Journal of Medical Genetics, 96, 784-790.
19. Peters, J., & Beechey, C. (2004). Identification and characterisation of imprinted genes in the mouse. Briefings in Functional Genomics and Proteomics, 2, 320-333.
20. Resta, R., & Thompson, L. F. (1997). SCID: the role of adenosine deaminase deficiency. Immunology Today, 18, 371-374.
21. Robinson, P. D., Schutz, C. K., Macciardi, F., White, B. N., & Holden, J. J. A. (2001). Genetically determined low levels of maternal serum dopamine beta-hydroxylase and the etiology of autism spectrum disorders. American Journal of Medical Genetics, 100, 30-36.
22. Sham, P. C., & Curtis, D. (1995). An extended transmission/ disequilibrium test (TDT) for multi-allele marker loci. Annals of Human Genetics, 59, 323-336.
23. Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997). Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatric Neurology, 17, 88-90.
24. Stathis, S. L., Cowley, D. M., & Broe, D. (2000). Autism and adenylosuccinase deficiency. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 274-275.
25. Stone, R. L., Aimi, J., Barshop, B. A., Jaeken, J., Van den Berghe, G., Zalkin, H., et al. (1992). A mutation in adenylosuccinate lyase associated with mental retardation and autistic features. Nature Genetics, 1, 59-63.
26. Stubbs, G., Litt, M., Lis, E., Jackson, R., Voth, W., Lindberg, A., et al. (1982). Adenosine deaminase activity decreased in autism. Journal of the American Academy of Child Psychiatry, 21, 71-74.
27. Trottier, G., Srivastava, L., & Walker, C-D. (1999). Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. Journal of Psychiatry & Neuroscience, 24, 103-115.
28. Van Steen, K., & Laird, N. M. (2004). Family-based association tests and the FBAT-toolkit. User's manual. Retrieved January 28, 2006, from http://www.biostat.harvard.edu/∼fbat/manual.mar4.doc
29. Weissmann, J., Volmer, M., & Pribilla, O. (1982). Survey of the distribution of adenosine deaminase and superoxide dismutase markers in different populations. Human Heredity, 32, 344-356.
30. Zoroglu, S. S., Armutcu, F., Ozen, S., Gurel, A., Sivasli, E., Yetkin, O., et al. (2004). Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. European Archives of Psychiatry and Clinical Neuroscience, 254, 143-147.